CN ENERGY GROUP INC-A (CNEY)

VGG2181K1131 - Common Stock

0.335  -0.08 (-20.05%)

Premarket: 0.329 -0.01 (-1.79%)

Fundamental Rating

2

Taking everything into account, CNEY scores 2 out of 10 in our fundamental rating. CNEY was compared to 84 industry peers in the Chemicals industry. CNEY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CNEY has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year CNEY has reported negative net income.
CNEY had a negative operating cash flow in the past year.
CNEY had positive earnings in 4 of the past 5 years.
In the past 5 years CNEY reported 4 times negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -3.72%, CNEY is not doing good in the industry: 74.39% of the companies in the same industry are doing better.
CNEY's Return On Equity of -4.29% is on the low side compared to the rest of the industry. CNEY is outperformed by 69.51% of its industry peers.
Industry RankSector Rank
ROA -3.72%
ROE -4.29%
ROIC N/A
ROA(3y)-0.55%
ROA(5y)2.54%
ROE(3y)-0.47%
ROE(5y)3.6%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CNEY does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

CNEY does not have a ROIC to compare to the WACC, probably because it is not profitable.
CNEY has less shares outstanding than it did 1 year ago.
CNEY has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CNEY has a worse debt to assets ratio.

2.2 Solvency

CNEY has an Altman-Z score of 1.01. This is a bad value and indicates that CNEY is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.01, CNEY is doing worse than 79.27% of the companies in the same industry.
A Debt/Equity ratio of 0.08 indicates that CNEY is not too dependend on debt financing.
The Debt to Equity ratio of CNEY (0.08) is better than 87.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 1.01
ROIC/WACCN/A
WACC7.19%

2.3 Liquidity

A Current Ratio of 4.40 indicates that CNEY has no problem at all paying its short term obligations.
The Current ratio of CNEY (4.40) is better than 91.46% of its industry peers.
CNEY has a Quick Ratio of 4.14. This indicates that CNEY is financially healthy and has no problem in meeting its short term obligations.
CNEY's Quick ratio of 4.14 is amongst the best of the industry. CNEY outperforms 92.68% of its industry peers.
Industry RankSector Rank
Current Ratio 4.4
Quick Ratio 4.14

3

3. Growth

3.1 Past

CNEY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -94.10%.
The Revenue has grown by 35.10% in the past year. This is a very strong growth!
CNEY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 48.23% yearly.
EPS 1Y (TTM)-94.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.46%
Revenue 1Y (TTM)35.1%
Revenue growth 3Y66.8%
Revenue growth 5Y48.23%
Sales Q2Q%37.97%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CNEY. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CNEY!.
Industry RankSector Rank
Dividend Yield N/A

CN ENERGY GROUP INC-A

NASDAQ:CNEY (1/8/2025, 8:00:00 PM)

Premarket: 0.329 -0.01 (-1.79%)

0.335

-0.08 (-20.05%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.9%
Inst Owner Change-28.1%
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap2.79M
Analysts0
Price TargetN/A
Short Float %1.16%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 0.03
P/tB 0.03
EV/EBITDA N/A
EPS(TTM)-2.33
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS7.99
BVpS12.36
TBVpS12.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.72%
ROE -4.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-0.55%
ROA(5y)2.54%
ROE(3y)-0.47%
ROE(5y)3.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.41%
Cap/Sales 1.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.4
Quick Ratio 4.14
Altman-Z 1.01
F-Score4
WACC7.19%
ROIC/WACCN/A
Cap/Depr(3y)218.65%
Cap/Depr(5y)148.33%
Cap/Sales(3y)10.67%
Cap/Sales(5y)8.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-94.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35.1%
Revenue growth 3Y66.8%
Revenue growth 5Y48.23%
Sales Q2Q%37.97%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y71.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.65%
OCF growth 3YN/A
OCF growth 5YN/A